NEW YORK, April 14, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of Amplitude, Inc. (NASDAQ: AMPL) between September 21, 2021 and February 16, 2022, both dates inclusive (the

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of iRobot Corporation (NASDAQ: IRBT) between August 5, 2022 and January 26, 2024, both dates inclusive (the “Class Period”),

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Innoviz Technologies Ltd. (NASDAQ: INVZ, INVZW) between April 21, 2021 and February 28, 2023, both dates inclusive (the

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of bluebird bio, Inc. (NASDAQ: BLUE) between April 24, 2023 and December 8, 2023, both dates inclusive (the

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Autodesk, Inc. (NASDAQ: ADSK) resulting from allegations that Autodesk may have issued

Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer Mont-Saint-Guibert, Belgium – April 11, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and

NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Banco Santander, S.A. (NYSE: SAN) resulting from allegations that Santander may have